House Rejects Medical Marijuana Testing Bill, Leaving Future Oversight in Limbo

Maine’s push to tighten oversight of its medical marijuana market has stalled after the House overwhelmingly rejected a key testing and tracking bill, LD 1847. The proposal, authored by Rep. Anne Graham, D-Newport, would have required batch testing and product tracking for medical cannabis, with state cost assistance for smaller caregivers earning under 125,000 dollars a year. Caregiver and industry leader Shanna Souza agreed safety is critical but argued the measure would be too costly and could force hundreds of the state’s estimated 1,600 caregivers out of business.

Opponents, led by Rep. David Boyer, R-Portland, questioned the need for stricter rules, asking, “Where are the bodies? Where is the harm?” The House voted 102–43 against Graham’s bill, rejected alternative regulatory plans, and unanimously moved to shelve the effort. The issue now heads to the Senate, which could act as early as Monday. Read the original report on Yahoo News.